Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:52 2026-07-31 am EDT			5-day change	1st Jan Change
2,653.45 ^INR	+1.68%		+5.58%	+7.39%

May. 29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
May. 13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	449,510	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	16.21%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	449,510	449,510
Change	-	-18.99%	58.51%	48.08%	-20.64%	16.21%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	39.1x	34.7x
PBR	10.6x	12.9x	18.5x	25x	17.1x	17.1x	13.5x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.5x	2.7x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	10.7x	9.67x
EV / Revenue	0x	0x	0x	0x	0x	10.7x	9.67x
EV / EBITDA	0x	0x	0x	0x	0x	30.8x	27.3x
EV / EBIT	0x	0x	0x	0x	0x	32.7x	28.6x
EV / FCF	0x	0x	0x	0x	0x	38.8x	35x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.58%	2.86%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.11%	1.11%
EPS ²	100	36.05	34.83	54.76	61.15	67.9	76.48
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.4%	38.6%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,989	46,489
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,603	16,493
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,417	12,543
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,653.45	2,653.45
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	39.08x	-	-	1.11%	4.71B
ELI LILLY AND COMPANY	34.12x	12.19x	25.61x	0.59%	1,024B
JOHNSON & JOHNSON	27.48x	6.29x	17.41x	2.1%	618B
ABBVIE INC.	32.84x	7.42x	15.35x	2.76%	443B
ROCHE HOLDING AG	19.59x	4.68x	11.59x	2.83%	349B
NOVARTIS AG	22.21x	5.74x	14.32x	2.8%	297B
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	264B
NOVO NORDISK A/S	13.48x	5.04x	10.4x	3.7%	209B
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	208B
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	162B
Average	18.89x	6.45x	16.68x	2.3%	357.85B
Weighted average by Cap.	24.13x	7.70x	18.21x	2.01%